Pathology News
admin

About admin@pathologynews.com

This author has not yet filled in any details.
So far admin@pathologynews.com has created 1088 blog entries.

September 2024

Aiosyn’s NephroPath GlomeruCount Introduces AI-Powered Kidney Image Analysis to Sectra Amplifier Marketplace

2024-09-18T12:14:37+00:00

Aiosyn, a pioneering pathology software company specializing in AI-powered solutions for kidney disease and breast cancer, has integrated its glomerular quantification algorithm with Sectra’s diagnostic application for pathology. As the first solution for kidney biopsy analysis featured on Sectra Amplifier Marketplace, NephroPath GlomeruCount* allows kidney pathology laboratories to boost the efficiency of tissue evaluations.

Aiosyn’s NephroPath GlomeruCount Introduces AI-Powered Kidney Image Analysis to Sectra Amplifier Marketplace2024-09-18T12:14:37+00:00

AI-based Digital Histopathology For Perihilar Cholangiocarcinoma: A Step, Not A Jump

2025-08-13T14:32:38+00:00

Perihilar cholangiocarcinoma (PHCC), also known as Klatskin tumors, represents one of the most challenging malignancies in oncology. With an incidence rate of 1-2 cases per 100,000 individuals in the Western world, this rare cancer is characterized by late diagnosis and poor long-term survival rates, even with curative surgical treatment. Artificial intelligence (AI) has emerged as a promising tool in oncology, particularly through AI-based digital histopathology, offering the potential to improve prognostic predictions in various cancers, including PHCC. However, while AI offers significant advancements, its role in PHCC remains a step forward, but not yet the leap required for clinical impact.

AI-based Digital Histopathology For Perihilar Cholangiocarcinoma: A Step, Not A Jump2025-08-13T14:32:38+00:00

10x Genomics Unveils Chromium Xo: A Low-Cost Instrument to Expand Access to High-Performance Single Cell Research

2025-06-26T16:04:34+00:00

10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced the launch of Chromium Xo, a new addition to its fleet of Chromium single cell instruments. Designed to meet the needs of researchers who desire high-quality data on limited budgets, Chromium Xo offers an affordable entry point into routine, high-performance single cell analysis.

10x Genomics Unveils Chromium Xo: A Low-Cost Instrument to Expand Access to High-Performance Single Cell Research2025-06-26T16:04:34+00:00

Fimlab Is Adopting Proscia’s Software To Realize The Promise Of AI-Enabled Pathology

2024-09-13T13:39:46+00:00

Fimlab Laboratories, Finland’s largest provider of laboratory services, research, and training, is taking the next step on its digital pathology journey with Proscia®, a global leader in AI-enabled pathology solutions for precision medicine. The company will use Proscia’s software platform to help its pathologists generate more precise results with artificial intelligence (AI).

Fimlab Is Adopting Proscia’s Software To Realize The Promise Of AI-Enabled Pathology2024-09-13T13:39:46+00:00

PathAI Launches MET Predict on AISight to Enhance NSCLC Assessments

2024-09-11T09:49:03+00:00

PathAI, a global leader in artificial intelligence (AI) and digital pathology solutions, today announced the launch of MET Predict† on the AISightⓇ† Image management system (IMS). MET Predict is an AI-powered algorithm designed to help pathologists identify non-small cell lung cancer (NSCLC) tumors that may be more likely to have MET exon 14 skipping (METex14) or MET amplification, directly from an H&E whole slide image.

PathAI Launches MET Predict on AISight to Enhance NSCLC Assessments2024-09-11T09:49:03+00:00

Proscia And Smart Reporting Partner To Help Pathologists Guide Clinical Care Teams

2024-09-11T09:02:03+00:00

Proscia®, a global leader in AI-enabled pathology solutions for precision medicine, and Smart Reporting, a leading provider of medical documentation software, have partnered to help pathologists inform treatment decisions. The companies will deliver a unified experience around a product integration that enables pathologists to efficiently make and comprehensively report on precise diagnoses, all within a single user interface.

Proscia And Smart Reporting Partner To Help Pathologists Guide Clinical Care Teams2024-09-11T09:02:03+00:00

All-Inclusive Tickets to the Digital Diagnostic Summit Sold Out – Virtual Access Now Available!

2024-09-10T14:03:25+00:00

Click the button below to register for your DDx virtual access tickets. All-inclusive tickets to this year's highly anticipated Digital Diagnostic Summit (DDx) have officially sold out. If you missed your chance to secure one, there’s good news: the DDx Summit is offering Virtual Access tickets, meaning you can still participate in the event remotely. With this [...]

All-Inclusive Tickets to the Digital Diagnostic Summit Sold Out – Virtual Access Now Available!2024-09-10T14:03:25+00:00

Imagene Partners with Oracle to Launch CanvOI on Oracle Cloud Infrastructure

2024-09-10T12:00:42+00:00

Oracle and Imagene, a pioneer in AI-based precision oncology, today announced CanvOI, a state-of-the-art pan-cancer foundation model designed to facilitate innovative research and development in the digital pathology and oncology space. Running on Oracle Cloud Infrastructure (OCI), CanvOI captures the complex features and patterns within biopsy images, providing valuable oncology intelligence that could improve the way cancer is diagnosed and treated around the world.

Imagene Partners with Oracle to Launch CanvOI on Oracle Cloud Infrastructure2024-09-10T12:00:42+00:00

Roche Advances AI-Driven Cancer Diagnostics by Expanding Its Digital Pathology Open Environment

2024-09-10T08:40:20+00:00

The seamless integration is facilitated through Roche's navify® Digital Pathology enterprise software, an application for the pathologist's workflow, which now incorporates a diverse range of AI-driven algorithms, creating easy access to third-party innovation. These AI tools are designed to enhance pathology insights, helping benefit cancer patients through precision medicine and enabling targeted treatments.

Roche Advances AI-Driven Cancer Diagnostics by Expanding Its Digital Pathology Open Environment2024-09-10T08:40:20+00:00

Life Sciences Organizations Gain New Real-World Data Offering To Bring Precision Therapies And Diagnostics To Patients

2024-09-09T14:05:20+00:00

Life sciences organizations can now tap into de-identified real-world data from one of the most comprehensive repositories of pathology images alongside corresponding clinical and genomic data to accelerate the next breakthroughs in personalized care. Following a successful year-long pilot, Proscia®, a global leader in AI-enabled pathology solutions for precision medicine, today announced the availability of a real-world data offering on its Concentriq® platform.

Life Sciences Organizations Gain New Real-World Data Offering To Bring Precision Therapies And Diagnostics To Patients2024-09-09T14:05:20+00:00
Legal

Bioincyte Ltd is registered in the United Kingdom
under company number 13037659

Get in touch

© Copyright 2025, Bioincyte Ltd

Fields marked with an asterisk (*) are required.
By submitting you agree to our T&C and Privacy Policy

Go to Top